Anti-C1q antibodies as a marker for disease activity in systemic lupus erythematosus and lupus nephritis

Study for The Relationship between Lupus Nephritis and Anti-C1q Antibodies

Study of Anti-nucleosome Antibodies as A Predictor of Early Renal Affection in Systemic Lupus Erythematosus Patients

Anti-C1q antibodies as a specific serological marker In patients with active lupus nephritis

Anti-Nucleosome Antibody as a Marker of Systemic Lupus Erythematosus Activity

Utility of Serum Anti-C1q Autoantibodies as a Biomarker of Lupus Nephritis in Children

The Role of T-cell Immunoglobulin and Mucin Domain-Containing Molecule-3 as Disease Activity Marker in Systemic Lupus Erythematosus

Role of Tenascin-C in Systemic Lupus Erythematosus and Its Association with Disease Activity: Review Article

Beta 2 Microglobulin and Cystatin C in Systemic Lupus Erythematosus Patients: Correlation with Disease Activity

Clinical importance of C1q antibodies in systemic lupus patients with and without nephritis